J&J agrees to pay $20.4million in opioid addiction case

To avoid a trial in Ohio, US healthcare giant Johnson & Johnson reached a $20.4million settlement for allegedly fuelling the opioid addiction crisis. Several drugmakers have agreed deals ahead of the trial, due to open this month, which is seen as a national test case for many $billions in settlements.